Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre B) track

Biomarkers/Diagnostics/Imaging: SeNostic GmbH

Mon, Nov 9, 2026 · 1:45–2:00 PM CET Koelnmesse

About this session

SeNostic GmbH is a biotechnology company specializing in drug discovery, drug screening, and diagnosis of neurodegenerative disorders like Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis (ALS) as well as Diabetes Type 2. Our proprietary SeedCycler® technology detects disease-specific biomarkers years before symptoms appear, offering high sensitivity and specificity. This platform aids in differential diagnosis and patient stratification by screening therapeutic candidates that influence protein aggregation.

Speaker